Tumor bioengineering using a transglutaminase crosslinked hydrogel.

Development of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantag...

Full description

Bibliographic Details
Main Authors: Josephine Y Fang, Shih-Jye Tan, Zhi Yang, Charisse Tayag, Bo Han
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4136878?pdf=render
id doaj-194be2ca2cf04ec5bee4c41892144ca7
record_format Article
spelling doaj-194be2ca2cf04ec5bee4c41892144ca72020-11-25T01:44:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10561610.1371/journal.pone.0105616Tumor bioengineering using a transglutaminase crosslinked hydrogel.Josephine Y FangShih-Jye TanZhi YangCharisse TayagBo HanDevelopment of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantages over other alternatives including presenting cell-matrix interaction sites from collagen-derived peptides, geometry-initiated multicellular tumor spheroids, and metabolic gradients in the tumor microenvironment. Also it provides a controllable wide spectrum of gel stiffness for mechanical signals, and technical compatibility with imaging based screening due to its transparent properties. In addition, the Col-Tgel provides a cure-in-situ delivery vehicle for tumor xenograft formation in animals enhancing tumor cell uptake rate. Overall, this distinctive 3D system could offer a platform to more accurately mimic in vivo situations to study tumor formation and progression both in vitro and in vivo.http://europepmc.org/articles/PMC4136878?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Josephine Y Fang
Shih-Jye Tan
Zhi Yang
Charisse Tayag
Bo Han
spellingShingle Josephine Y Fang
Shih-Jye Tan
Zhi Yang
Charisse Tayag
Bo Han
Tumor bioengineering using a transglutaminase crosslinked hydrogel.
PLoS ONE
author_facet Josephine Y Fang
Shih-Jye Tan
Zhi Yang
Charisse Tayag
Bo Han
author_sort Josephine Y Fang
title Tumor bioengineering using a transglutaminase crosslinked hydrogel.
title_short Tumor bioengineering using a transglutaminase crosslinked hydrogel.
title_full Tumor bioengineering using a transglutaminase crosslinked hydrogel.
title_fullStr Tumor bioengineering using a transglutaminase crosslinked hydrogel.
title_full_unstemmed Tumor bioengineering using a transglutaminase crosslinked hydrogel.
title_sort tumor bioengineering using a transglutaminase crosslinked hydrogel.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Development of a physiologically relevant 3D model system for cancer research and drug development is a current challenge. We have adopted a 3D culture system based on a transglutaminase-crosslinked gelatin gel (Col-Tgel) to mimic the tumor 3D microenvironment. The system has several unique advantages over other alternatives including presenting cell-matrix interaction sites from collagen-derived peptides, geometry-initiated multicellular tumor spheroids, and metabolic gradients in the tumor microenvironment. Also it provides a controllable wide spectrum of gel stiffness for mechanical signals, and technical compatibility with imaging based screening due to its transparent properties. In addition, the Col-Tgel provides a cure-in-situ delivery vehicle for tumor xenograft formation in animals enhancing tumor cell uptake rate. Overall, this distinctive 3D system could offer a platform to more accurately mimic in vivo situations to study tumor formation and progression both in vitro and in vivo.
url http://europepmc.org/articles/PMC4136878?pdf=render
work_keys_str_mv AT josephineyfang tumorbioengineeringusingatransglutaminasecrosslinkedhydrogel
AT shihjyetan tumorbioengineeringusingatransglutaminasecrosslinkedhydrogel
AT zhiyang tumorbioengineeringusingatransglutaminasecrosslinkedhydrogel
AT charissetayag tumorbioengineeringusingatransglutaminasecrosslinkedhydrogel
AT bohan tumorbioengineeringusingatransglutaminasecrosslinkedhydrogel
_version_ 1725027219649069056